Sixty pharmaceutical companies have already kicked off 2019 by increasing list prices on nearly 300 drugs, according to one analysis.
Updated: 01/03/2019 04:56P
Sixty-two public companies with a combined market value of about $170 billion, the majority of them biotechnology firms, call Cambridge home. Global pharmaceutical giants, including Takeda Pharmaceutical Co., Sanofi SA and Novartis AG, also have ...
Updated: 10/05/2018 09:40A